Cyclooxygenase-2 expression in uterine leiomyosarcomas

Journal of Chemotherapy

Volumn 16, Issue 6, 2004, Pages 577-581

  Raspollini, Maria Rosario ^a   Amunni, G ^a   Villanucci, A ^a   Paglierani, M ^a   Taddei, G L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cyclooxygenase 2; Prognosis; Therapy; Uterine leiomyosarcoma

Indexed keywords

CISPLATIN; CYCLOOXYGENASE 2; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CANCER STAGING; CARCINOSARCOMA; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LEIOMYOSARCOMA; MOLECULAR BIOLOGY; OSTEOSARCOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RHABDOMYOSARCOMA; UTERUS MYOMA;

EID: 12544254068     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2004.16.6.577     Document Type: Article

References (32)

1. Silverberg SG. Leiomyosarcoma of the uterus. A clinicopathologic study. Obstet Gynecol 1971; 38: 613-628.
2. Gadducci A, Landoni F, Sartori E, et al. Uterine leiomyosarcoma: analysis of treatment failures and survival. Gynecol Oncol 1996; 62(1): 25-32.
3. De Paco G, Stefanon B, Raspaglieli F. Neoplasie del corpo dell'utero in Bonadonna G, Robustelli della Cuna G. Medicina oncologica. (6th edition), Masson, Milano-Paris-Barcellona, 1999.
4. DuBois RN, Giardiello FM, Smalley WE. Non steroidal anti-inflammatory drugs, eicosanoids and colorectal cancer. Gastroenterol Clin North Am 25: 773-791, 1996.
5. Norris AE, Jackson RT, McRae C et al. Non steroidal anti-inflammatory drug and prostate cancer progression. Int J Cancer 1998; 77: 511-515.
6. Harris RE, Namboodiri KK, Farrar WB et al. Non steroidal anti-inflammatory drugs and breast cancer. Epidemiology 1996; 7: 203-205.
7. Gupta RA, Dubois RN. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 2001; 1: 11-21.
8. Howe LR, Subbaramaiah K, Patel J et al. Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 HER-2)/neu-induced breast cancer. Cancer Res 2002; 62: 5405-5407.
9. Dannenberg AJ, Altorki NK, Boyle JO et al. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol 2001; 2: 544-551.
10. Williams CS, Mann M, DuBois RN. The role of cyclooxygenase in inflammation, cancer, and development. Oncogene 1999; 18: 7908-7916.
11. Howe LR, Crawford HC, Subbaramaiah K et al. PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2. J Biol Chem 20108-20115, 2001.
12. Thomas B, Berenbaum F, Humbert L, et al. Critical role of C/EBP delta and C/EBP beta factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1 beta in articular chondrocytes. Eur J Biochem 2000; 267: 6798-6809.
13. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995; 55: 3785-3789.
14. Tomozawa S, Tsuno NH, Sunamio E, et al. Cyclooxygenase-2 overexpression correlates with tumor recurrence, especially haematogenous metastasis of colorectal cancer. Br J Cancer 2000; 83: 324-328.
15. Denkert C, Kobel M, Pest S, et al. Expression of cyclooxygenase-2 is an independent prognostic factor in human ovarian carcinoma. Am J Pathol 2002; 160: 893-903.
16. Ferrandina G, Legge F, Ranelletti FO, et al. Cyclooxygenase-2 expression in endometrial carcinoma: correlation with clinicopathologic parameters and clinical outcome. Cancer 2002; 95(4): 801-807.
17. DiSaia PJ, Bloss JD. Treatment of ovarian cancer: new strategies. Gynecol Oncol 2003; S24-S32.
18. Tamura M, Sebastian S, Yang S, et al. Up-regulation of cyclooxygenase-2 expression and prostaglandin synthesis in endometrial stromal cells by malignant endometrial epithelial cells. A paracrine effect mediated by prostaglandine E2 and nuclear factor kB. J Biol Chem 2002; 227(29): 26208-26216.
19. th ed./editor 2002, Robert J Kurmann. Spriner-Verlag New York Berlin Heidelberg.
20. Matsumoto Y, Ishiko O, Sumi T, et al. Cyclooxygenase-2 expression in malignant mesenchymal tumors and related uterine lesions. Oncol Rep 2001; 8: 1225-1227.
21. Kaplan EL, Meier P. Nonparametric estimationfrom incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
22. TNM Classification of malignant tumours. UICC. Sobin LH and Wittekind Ch Editors. Geneva, Switzerland. Sixth ed. 2002.
23. Mayerhofer K, Obermairn A, Windbichler G, et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 1999; 74: 196-201.
24. Subbaramaiah K, Zakim D, Weksler BB et al. Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc Soc Exp Biol Med 1997; 216: 201-210.
25. Huang M, Stolina M, Sharma S et al. Non small cell lung cancer cyclooxygenase-2-dependent regulation of cytochine balance in lymphocytes and macrophages: up regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Res 1998; 58: 1208-1216.
26. Madaan S, Abel PD, Chaudhari KS et al. Cytoplasmatic induction and overexpression of cyclooxygenase-2 in human prostate cancer: implication for prevention and treatment: Br J Urol 2000; 86: 736-741.
27. Tucker ON, Dannemberg AJ, Yang EK et al. Cyclooxygenase-2 expression is upregulated in human pancreatic cancer. Cancer Res 1999; 59: 987-990.
28. Ohno R, Yoshinaga K, Fujita T et al. Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma. Cancer 2001; 91: 1876-1881.
29. Tsujii M, Kawano S, DuBois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997; 94: 3336-3340.
30. Raspollini MR, Amunni G, Villanucci A et al. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in ovarian cancer: Correlation with clinical outcome. Gynecol Oncol 2004; 92(3): 806-812.
31. Dickens DS, Kozielski R, Leavey PJ, Timmons C, Cripe TP. Cyclooxygenase-2 expression does not correlate with outcome in osteosarcoma or rhabdomyosarcoma. J Pediatr Hematol Oncol 2003; 25(4): 282-285.
32. Dickens DS, Kozielski R, Khan J, Forus A, Cripe TP. Cyclooxygenase-2 expression in pediatric sarcomas. Pediatr Dev Pathol 2002; 5(4): 356-364.